BIOSPECIFICS TECHNOLOGIES CORP·4

Dec 15, 6:19 PM ET

Morgan Henry 4

4 · BIOSPECIFICS TECHNOLOGIES CORP · Filed Dec 15, 2009

Insider Transaction Report

Form 4
Period: 2009-12-11
Morgan Henry
Director
Transactions
  • Sale

    Common Stock

    2009-12-11$30.04/sh11,254$338,09032,274 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2009-12-1110,000164,425 total
    Exercise: $1.00From: 2002-04-19Exp: 2011-04-18Common Stock, $.001 par value (10,000 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2009-12-1110,000174,425 total
    Exercise: $2.56From: 2005-06-05Exp: 2010-06-04Common Stock, $.001 par value (10,000 underlying)
  • Exercise/Conversion

    Common Stock

    2009-12-11$2.56/sh+10,000$25,63033,528 total
  • Exercise/Conversion

    Common Stock

    2009-12-11$1.00/sh+10,000$10,00043,528 total
  • Sale

    Common Stock

    2009-12-14$30.36/sh200$6,07132,074 total

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES